147 related articles for article (PubMed ID: 6145520)
1. The reversibility of "permanent" tardive dyskinesia.
Klawans HL; Tanner CM; Barr A
Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520
[TBL] [Abstract][Full Text] [Related]
2. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
Morgenstern H; Glazer WM
Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
[TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E
Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia in schizophrenics under 60 years of age.
Kolakowska T; Williams AO; Ardern M; Reveley MA
Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
[TBL] [Abstract][Full Text] [Related]
5. Early course of new-onset tardive dyskinesia in older patients.
Lacro JP; Gilbert PL; Paulsen JS; Fell R; Bailey A; Juels C; Caligiuri M; McAdams LA; Harris MJ; Jeste DV
Psychopharmacol Bull; 1994; 30(2):187-91. PubMed ID: 7831454
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
Soares-Weiser K; Rathbone J
Cochrane Database Syst Rev; 2006 Jan; (1):CD000459. PubMed ID: 16437425
[TBL] [Abstract][Full Text] [Related]
7. Predictors of improvement in tardive dyskinesia following discontinuation of neuroleptic medication.
Glazer WM; Morgenstern H; Schooler N; Berkman CS; Moore DC
Br J Psychiatry; 1990 Oct; 157():585-92. PubMed ID: 1983390
[TBL] [Abstract][Full Text] [Related]
8. Abnormal involuntary movements in patients on long-acting neuroleptics.
Oyewumi LK; Lapierre YD; Gray R; Batth S; Gelfand R
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):719-23. PubMed ID: 6141614
[TBL] [Abstract][Full Text] [Related]
9. Treatment of late-life schizophrenia with neuroleptics.
Jeste DV; Lacro JP; Gilbert PL; Kline J; Kline N
Schizophr Bull; 1993; 19(4):817-30. PubMed ID: 7905663
[TBL] [Abstract][Full Text] [Related]
10. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
McGrath JJ; Soares KV
Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
[TBL] [Abstract][Full Text] [Related]
12. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
[TBL] [Abstract][Full Text] [Related]
13. [Never treated schizophrenic patients have no abnormal movements such as tardive dyskinesia].
Chorfi M; Moussaoui D
Encephale; 1985; 11(6):263-5. PubMed ID: 2869939
[TBL] [Abstract][Full Text] [Related]
14. The current status of tardive dyskinesia.
Sachdev PS
Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
[TBL] [Abstract][Full Text] [Related]
15. Tardive dyskinesia--reversible and persistent.
Jeste DV; Potkin SG; Sinha S; Feder S; Wyatt RJ
Arch Gen Psychiatry; 1979 May; 36(5):585-90. PubMed ID: 35116
[TBL] [Abstract][Full Text] [Related]
16. Tardive dyskinesia. A discontinuation study.
Glazer WM; Moore DC; Schooler NR; Brenner LM; Morgenstern H
Arch Gen Psychiatry; 1984 Jun; 41(6):623-7. PubMed ID: 6145399
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia.
Jeste DV; Caligiuri MP
Schizophr Bull; 1993; 19(2):303-15. PubMed ID: 8100643
[TBL] [Abstract][Full Text] [Related]
18. The natural history of tardive dystonia. A long-term follow-up study of 107 cases.
Kiriakakis V; Bhatia KP; Quinn NP; Marsden CD
Brain; 1998 Nov; 121 ( Pt 11)():2053-66. PubMed ID: 9827766
[TBL] [Abstract][Full Text] [Related]
19. Changes in prevalence, severity, and recovery in tardive dyskinesia with age.
Smith JM; Baldessarini RJ
Arch Gen Psychiatry; 1980 Dec; 37(12):1368-73. PubMed ID: 6108750
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic medication facilitates the natural occurrence of tardive dyskinesia. A critical review.
Driesens F
Acta Psychiatr Belg; 1988; 88(3):195-205. PubMed ID: 2906780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
